Person · CIK 1340823

Mary Lynne Hedley

Director at Veeva Systems, Centessa Pharmaceuticals and Eli Lilly

Earlier: Millendo Therapeutics, TESARO, bluebird bio, Receptos, Abraxis BioScience and Mgi Pharma

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$1.1M

Noticed on Form 144$63K

Bought on Form 4$0

Companies9

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Veeva Systems VEEV	Class A Common Stock	Directly	7,629	Sep 1, 2026 · Filing · EDGAR
Veeva Systems VEEV	Restricted Stock Units into Class A Common Stock	Directly	1,429	Sep 1, 2026 · Filing · EDGAR
Eli Lilly LLY	Common Stock	Directly	2,252.69	Dec 15, 2025 · Filing · EDGAR
Eli Lilly LLY	Common Stock	By Trust	98	Dec 15, 2025 · Filing · EDGAR
Millendo Therapeutics	Stock Option (right to buy) exercise $2.40, expires Jun 21, 2030, into Common Stock	Directly	12,000	Jun 22, 2020 · Filing · EDGAR
bluebird bio	Common Stock	Directly	3,700	Jun 20, 2018 · Filing · EDGAR
bluebird bio	Stock Option (right to buy) exercise $183.10, expires Jun 20, 2028, into Common Stock	Directly	4,000	Jun 20, 2018 · Filing · EDGAR
Abraxis BioScience	Restricted Stock Units	Directly	25,000	Jul 13, 2009 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q4 2023	$16K	$16K
Q3 2023	$48K	$48K
Q3 2021	$30K	Not machine-readable
Q2 2021	$26K	Not machine-readable
Q1 2021	$27K	Not machine-readable
Q1 2018	$211K	Not machine-readable
Q1 2017	$697K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Veeva Systems VEEV · Merrill Lynch · 10b5-1 plan adopted Sep 27, 2023 · 1 notice
Dec 27, 2023	83 · ~$16K	Dec 27, 2023	Sold as noticed Sold 83 in 2 sales, Dec 27 to Dec 28 · $16K Form 4	Filing · EDGAR
Veeva Systems VEEV · Merrill Lynch · 10b5-1 plan adopted Apr 12, 2023 · 1 notice
Jul 12, 2023	230 · ~$48K	Jul 12, 2023	Sold as noticed Sold 230 in 2 sales, Jul 12 to Jul 13 · $48K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 5 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 94 at $314.81 on Jul 15, 2021 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 95 at $270.66 on Apr 14, 2021 · $26K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 95 at $288.54 on Jan 11, 2021 · $27K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable TESARO: Sold 3,855 at $54.86 on Mar 1, 2018 · $211K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable TESARO: Sold 3,927 at $177.61 on Mar 2, 2017 · $697K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Veeva Systems VEEV Director · filings 2019 to 2026 · sold $146K · $63K noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 1, 2026	Option or RSU exercised or converted	+477			7,629 direct	Filing · EDGAR
Sep 1, 2026	Option or RSU exercised or converted Restricted Stock Units	−477			1,429 direct	Filing · EDGAR
Jun 17, 2026	Grant or award from the company Restricted Stock Units	+1,906			1,906 direct	Filing · EDGAR
Jun 1, 2026	Option or RSU exercised or converted	+262			7,152 direct	Filing · EDGAR
Jun 1, 2026	Option or RSU exercised or converted Restricted Stock Units	−262			0 direct	Filing · EDGAR
Mar 1, 2026	Option or RSU exercised or converted	+262			6,890 direct	Filing · EDGAR
Mar 1, 2026	Option or RSU exercised or converted Restricted Stock Units	−262			262 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted	+263			6,628 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−263			524 direct	Filing · EDGAR
Sep 1, 2025	Option or RSU exercised or converted	+262			6,365 direct	Filing · EDGAR
Sep 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−262			787 direct	Filing · EDGAR
Jun 18, 2025	Grant or award from the company Restricted Stock Units	+1,049			1,049 direct	Filing · EDGAR
Jun 1, 2025	Option or RSU exercised or converted	+343			6,103 direct	Filing · EDGAR
Jun 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−343			0 direct	Filing · EDGAR
Mar 1, 2025	Option or RSU exercised or converted	+342			5,760 direct	Filing · EDGAR
Mar 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−342			343 direct	Filing · EDGAR
Dec 1, 2024	Option or RSU exercised or converted	+343			5,418 direct	Filing · EDGAR
Dec 1, 2024	Option or RSU exercised or converted Restricted Stock Units	−343			685 direct	Filing · EDGAR
Sep 1, 2024	Option or RSU exercised or converted	+343			5,075 direct	Filing · EDGAR
Sep 1, 2024	Option or RSU exercised or converted Restricted Stock Units	−343			1,028 direct	Filing · EDGAR
Jun 19, 2024	Grant or award from the company Restricted Stock Units	+1,371			1,371 direct	Filing · EDGAR
Jun 1, 2024	Option or RSU exercised or converted	+302			4,732 direct	Filing · EDGAR
Jun 1, 2024	Option or RSU exercised or converted Restricted Stock Units	−302			0 direct	Filing · EDGAR
Mar 1, 2024	Option or RSU exercised or converted	+302			4,430 direct	Filing · EDGAR
Mar 1, 2024	Option or RSU exercised or converted Restricted Stock Units	−302			302 direct	Filing · EDGAR
Dec 28, 2023	Sale under a 10b5-1 plan	−42	$191.07	$8K	4,128 direct	Filing · EDGAR
Dec 27, 2023	Sale under a 10b5-1 plan	−41	$190.96	$8K	4,170 direct	Filing · EDGAR
Dec 1, 2023	Option or RSU exercised or converted	+303			4,211 direct	Filing · EDGAR
Dec 1, 2023	Option or RSU exercised or converted Restricted Stock Units	−303			604 direct	Filing · EDGAR
Sep 1, 2023	Option or RSU exercised or converted	+302			3,908 direct	Filing · EDGAR
Sep 1, 2023	Option or RSU exercised or converted Restricted Stock Units	−302			907 direct	Filing · EDGAR
Jul 13, 2023	Sale under a 10b5-1 plan	−138	$208.31	$29K	3,606 direct	Filing · EDGAR
Jul 12, 2023	Sale under a 10b5-1 plan	−92	$207.20	$19K	3,744 direct	Filing · EDGAR
Jun 21, 2023	Grant or award from the company Restricted Stock Units	+1,209			1,209 direct	Filing · EDGAR
Jun 1, 2023	Option or RSU exercised or converted	+326			3,836 direct	Filing · EDGAR
Jun 1, 2023	Option or RSU exercised or converted Restricted Stock Units	−326			0 direct	Filing · EDGAR
Mar 1, 2023	Option or RSU exercised or converted	+327			3,510 direct	Filing · EDGAR
Mar 1, 2023	Option or RSU exercised or converted Restricted Stock Units	−327			326 direct	Filing · EDGAR
Dec 1, 2022	Option or RSU exercised or converted	+326			3,183 direct	Filing · EDGAR
Dec 1, 2022	Option or RSU exercised or converted Restricted Stock Units	−326			653 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted	+327			2,857 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted Restricted Stock Units	−327			979 direct	Filing · EDGAR
Jun 9, 2022	Grant or award from the company Restricted Stock Units	+1,306			1,306 direct	Filing · EDGAR
Jun 1, 2022	Option or RSU exercised or converted	+197			2,530 direct	Filing · EDGAR
Jun 1, 2022	Option or RSU exercised or converted Restricted Stock Units	−197			0 direct	Filing · EDGAR
Mar 1, 2022	Option or RSU exercised or converted	+197			2,333 direct	Filing · EDGAR
Mar 1, 2022	Option or RSU exercised or converted Restricted Stock Units	−197			197 direct	Filing · EDGAR
Dec 1, 2021	Option or RSU exercised or converted	+197			2,136 direct	Filing · EDGAR
Dec 1, 2021	Option or RSU exercised or converted Restricted Stock Units	−197			394 direct	Filing · EDGAR
Sep 1, 2021	Option or RSU exercised or converted	+197			1,939 direct	Filing · EDGAR
Sep 1, 2021	Option or RSU exercised or converted Restricted Stock Units	−197			591 direct	Filing · EDGAR
Jul 15, 2021	Sale under a 10b5-1 plan	−94	$314.81	$30K	1,742 direct	Filing · EDGAR
Jun 25, 2021	Option or RSU exercised or converted	+211			1,825 direct	Filing · EDGAR
Jun 25, 2021	Option or RSU exercised or converted	+11			1,836 direct	Filing · EDGAR
Jun 25, 2021	Option or RSU exercised or converted Restricted Stock Units	−211			0 direct	Filing · EDGAR
Jun 25, 2021	Option or RSU exercised or converted Restricted Stock Units	−11			0 direct	Filing · EDGAR
Jun 23, 2021	Grant or award from the company Restricted Stock Units	+788			788 direct	Filing · EDGAR
Apr 14, 2021	Sale under a 10b5-1 plan	−95	$270.66	$26K	1,614 direct	Filing · EDGAR
Mar 25, 2021	Option or RSU exercised or converted	+211			1,697 direct	Filing · EDGAR
Mar 25, 2021	Option or RSU exercised or converted	+12			1,709 direct	Filing · EDGAR

22 earlier transactions are in the filing list below.

Centessa Pharmaceuticals CNTA Director · filings 2021 to 2026

Date	Transaction	Shares	Held after	Source
Jun 24, 2026	Returned to the company Share Option (right to buy)	−208,474	0 direct	Filing · EDGAR
Jun 24, 2026	Returned to the company Share Option (right to buy)	−48,000	0 direct	Filing · EDGAR
Jun 24, 2026	Returned to the company Share Option (right to buy)	−48,000	0 direct	Filing · EDGAR
Jun 24, 2026	Returned to the company Share Option (right to buy)	−48,000	0 direct	Filing · EDGAR
Jun 24, 2026	Returned to the company Share Option (right to buy)	−40,000	0 direct	Filing · EDGAR
Jun 20, 2025	Grant or award from the company Share Option (right to buy)	+40,000	40,000 direct	Filing · EDGAR
Jun 25, 2024	Grant or award from the company Share Option (right to buy)	+48,000	48,000 direct	Filing · EDGAR
Jun 22, 2023	Grant or award from the company Share Option (right to buy)	+48,000	48,000 direct	Filing · EDGAR
Jun 30, 2022	Grant or award from the company Share Option (right to buy)	+48,000	48,000 direct	Filing · EDGAR

Eli Lilly LLY Director · filings 2022 to 2025

Date	Transaction	Shares	Price	Value	Held after	Source
Dec 15, 2025	Grant or award from the company	+9.34	$1,062.19	$10K	2,252.69 direct	Filing · EDGAR
Nov 17, 2025	Grant or award from the company	+9.71	$1,021.70	$10K	2,025.53 direct	Filing · EDGAR
Nov 17, 2025	Grant or award from the company	+215.33	$1,021.70	$220K	2,240.86 direct	Filing · EDGAR
Oct 20, 2025	Grant or award from the company	+12.26	$808.96	$10K	2,015.83 direct	Filing · EDGAR
Sep 15, 2025	Grant or award from the company	+13.25	$748.19	$10K	2,003.49 direct	Filing · EDGAR
Aug 18, 2025	Grant or award from the company	+14.21	$698.05	$10K	1,986.78 direct	Filing · EDGAR
Jul 21, 2025	Grant or award from the company	+13.01	$762.18	$10K	1,972.57 direct	Filing · EDGAR
Jun 16, 2025	Grant or award from the company	+12.28	$807.58	$10K	1,959.56 direct	Filing · EDGAR
May 19, 2025	Grant or award from the company	+13.13	$755.11	$10K	1,944.16 direct	Filing · EDGAR
Apr 21, 2025	Grant or award from the company	+12.12	$818.02	$10K	1,931.03 direct	Filing · EDGAR
Mar 17, 2025	Grant or award from the company	+12.02	$824.76	$10K	1,918.9 direct	Filing · EDGAR
Feb 18, 2025	Grant or award from the company	+11.57	$857.20	$10K	1,903.89 direct	Filing · EDGAR
Jan 21, 2025	Grant or award from the company	+13.36	$742.35	$10K	1,892.32 direct	Filing · EDGAR
Dec 16, 2024	Grant or award from the company	+12.73	$779.00	$10K	1,878.97 direct	Filing · EDGAR
Nov 18, 2024	Grant or award from the company	+13.64	$727.20	$10K	1,561.59 direct	Filing · EDGAR
Nov 18, 2024	Grant or award from the company	+302.53	$727.20	$220K	1,864.12 direct	Filing · EDGAR
Oct 21, 2024	Grant or award from the company	+11	$906.13	$10K	1,548 direct	Filing · EDGAR
Sep 16, 2024	Grant or award from the company	+11	$923.54	$10K	1,537 direct	Filing · EDGAR
Aug 19, 2024	Grant or award from the company	+11	$921.81	$10K	1,524 direct	Filing · EDGAR
Jul 15, 2024	Grant or award from the company	+10	$950.46	$10K	1,513 direct	Filing · EDGAR
Jun 17, 2024	Grant or award from the company	+11	$885.01	$10K	1,503 direct	Filing · EDGAR
May 20, 2024	Grant or award from the company	+13	$783.18	$10K	1,490 direct	Filing · EDGAR
Apr 15, 2024	Grant or award from the company	+13	$750.77	$10K	1,477 direct	Filing · EDGAR
Mar 18, 2024	Grant or award from the company	+13	$762.66	$10K	1,464 direct	Filing · EDGAR
Feb 20, 2024	Grant or award from the company	+13	$755.66	$10K	1,449 direct	Filing · EDGAR
Jan 16, 2024	Grant or award from the company	+16	$634.57	$10K	1,437 direct	Filing · EDGAR
Dec 18, 2023	Grant or award from the company	+17	$579.76	$10K	1,421 direct	Filing · EDGAR
Nov 20, 2023	Grant or award from the company	+17	$597.60	$10K	1,068 direct	Filing · EDGAR
Nov 20, 2023	Grant or award from the company	+335	$597.60	$200K	1,403 direct	Filing · EDGAR
Oct 16, 2023	Grant or award from the company	+16	$616.64	$10K	1,051 direct	Filing · EDGAR
Sep 18, 2023	Grant or award from the company	+17	$571.28	$10K	1,035 direct	Filing · EDGAR
Aug 21, 2023	Grant or award from the company	+18	$550.50	$10K	1,017 direct	Filing · EDGAR
Jul 17, 2023	Grant or award from the company	+22	$447.14	$10K	999 direct	Filing · EDGAR
Jun 20, 2023	Grant or award from the company	+22	$451.95	$10K	977 direct	Filing · EDGAR
May 15, 2023	Grant or award from the company	+23	$434.51	$10K	953 direct	Filing · EDGAR
Apr 17, 2023	Grant or award from the company	+27	$372.35	$10K	930 direct	Filing · EDGAR
Mar 20, 2023	Grant or award from the company	+30	$333.60	$10K	655 direct	Filing · EDGAR
Feb 21, 2023	Grant or award from the company	+30	$327.51	$10K	623 direct	Filing · EDGAR
Jan 17, 2023	Grant or award from the company	+28	$357.74	$10K	593 direct	Filing · EDGAR
Dec 19, 2022	Grant or award from the company	+28	$357.78	$10K	565 direct	Filing · EDGAR
Nov 21, 2022	Grant or award from the company	+27	$361.17	$10K	204 direct	Filing · EDGAR
Nov 21, 2022	Grant or award from the company	+332	$361.17	$120K	536 direct	Filing · EDGAR
Oct 17, 2022	Grant or award from the company	+30	$332.76	$10K	177 direct	Filing · EDGAR
Sep 19, 2022	Grant or award from the company	+33	$305.09	$10K	147 direct	Filing · EDGAR
Aug 15, 2022	Grant or award from the company	+32	$313.94	$10K	114 direct	Filing · EDGAR
Jul 18, 2022	Grant or award from the company	+31	$321.77	$10K	82 direct	Filing · EDGAR
Jun 21, 2022	Grant or award from the company	+33	$297.34	$10K	51 direct	Filing · EDGAR
May 16, 2022	Grant or award from the company	+18	$299.38	$5K	18 direct	Filing · EDGAR

Millendo Therapeutics Director · filings 2018 to 2020

Date	Transaction	Shares	Held after	Source
Jun 22, 2020	Grant or award from the company Stock Option (right to buy)	+12,000	12,000 direct	Filing · EDGAR
Jun 20, 2019	Grant or award from the company Stock Option (right to buy)	+12,000	12,000 direct	Filing · EDGAR
Jan 15, 2019	Grant or award from the company Stock Option (right to buy)	+6,000	6,000 direct	Filing · EDGAR
Dec 7, 2018	Grant or award from the company Stock Option (right to buy)	+18,600	18,600 direct	Filing · EDGAR

TESARO President & COO · filings 2012 to 2019 · sold $909K

Date	Transaction	Shares	Price	Value	Held after	Source
Jan 22, 2019	Tendered in a change of control	−26,816	$75.00	$2M	0 direct	Filing · EDGAR
Jan 22, 2019	Tendered in a change of control	−563,569	$75.00	$42.3M	0 See Footnote	Filing · EDGAR
Jan 22, 2019	Returned to the company Restricted Stock Units	−20,000			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Restricted Stock Units	−8,339			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Restricted Stock Units	−40,909			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Employee Stock Option (right to buy)	−285,714			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Employee Stock Option (right to buy)	−319,467			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Employee Stock Option (right to buy)	−175,000			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Employee Stock Option (right to buy)	−105,000			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Employee Stock Option (right to buy)	−115,000			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Employee Stock Option (right to buy)	−80,000			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Employee Stock Option (right to buy)	−20,216			0 direct	Filing · EDGAR
Jan 22, 2019	Returned to the company Employee Stock Option (right to buy)	−71,896			0 direct	Filing · EDGAR
Dec 20, 2018	Option or RSU exercised or converted	+23,390	$6.62	$155K	38,388 direct	Filing · EDGAR
Dec 20, 2018	Shares withheld for tax or exercise price	−11,572	$73.10	$846K	26,816 direct	Filing · EDGAR
Dec 20, 2018	Option or RSU exercised or converted Employee Stock Option (right to buy)	−23,390			296,101 direct	Filing · EDGAR
Mar 1, 2018	Option or RSU exercised or converted	+10,000			16,073 direct	Filing · EDGAR
Mar 1, 2018	Option or RSU exercised or converted	+2,780			18,853 direct	Filing · EDGAR
Mar 1, 2018	Sale under a 10b5-1 plan	−3,855	$54.86	$211K	14,998 direct	Filing · EDGAR
Mar 1, 2018	Option or RSU exercised or converted Restricted Stock Units	−10,000			20,000 direct	Filing · EDGAR
Mar 1, 2018	Option or RSU exercised or converted Restricted Stock Units	−2,780			8,339 direct	Filing · EDGAR
Mar 1, 2018	Grant or award from the company Restricted Stock Units	+40,909			40,909 direct	Filing · EDGAR
Mar 1, 2018	Grant or award from the company Employee Stock Option (right to buy)	+71,896			71,896 direct	Filing · EDGAR
Mar 2, 2017	Sale under a 10b5-1 plan	−3,927	$177.61	$697K	6,073 direct	Filing · EDGAR
Mar 1, 2017	Option or RSU exercised or converted	+10,000			10,000 direct	Filing · EDGAR
Mar 1, 2017	Option or RSU exercised or converted Restricted Stock Units	−10,000			30,000 direct	Filing · EDGAR
Mar 1, 2017	Grant or award from the company Restricted Stock Units	+11,119			11,119 direct	Filing · EDGAR
Mar 1, 2017	Grant or award from the company Employee Stock Option (right to buy)	+20,216			20,216 direct	Filing · EDGAR
Mar 1, 2016	Grant or award from the company Restricted Stock Units	+40,000			40,000 direct	Filing · EDGAR
Mar 1, 2016	Grant or award from the company Employee Stock Option (right to buy)	+80,000			80,000 direct	Filing · EDGAR
Mar 6, 2015	Grant or award from the company Employee Stock Option (right to buy)	+115,000			115,000 direct	Filing · EDGAR
Feb 27, 2014	Grant or award from the company Employee Stock Option (right to buy)	+105,000			105,000 direct	Filing · EDGAR
Mar 6, 2013	Grant or award from the company Employee Stock Option (right to buy)	+175,000			175,000 direct	Filing · EDGAR
Jul 3, 2012	Derivative converted	+71,428			563,569 direct	Filing · EDGAR
Jul 3, 2012	Derivative converted Series A Preferred Stock	−250,000			0 direct	Filing · EDGAR

bluebird bio Director · filings 2017 to 2018

Date	Transaction	Shares	Held after	Source
Jun 20, 2018	Grant or award from the company	+1,000	3,700 direct	Filing · EDGAR
Jun 20, 2018	Grant or award from the company Stock Option (right to buy)	+4,000	4,000 direct	Filing · EDGAR
Sep 18, 2017	Grant or award from the company	+2,700	2,700 direct	Filing · EDGAR
Sep 18, 2017	Grant or award from the company Stock Option (right to buy)	+10,700	10,700 direct	Filing · EDGAR

Receptos Director · filings 2014 to 2015

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 27, 2015	Returned to the company	−7,400	$232.00	$1.7M	0 direct	Filing · EDGAR
Aug 27, 2015	Returned to the company Stock Option (right to buy)	−18,800	$194.27	$3.7M	0 direct	Filing · EDGAR
Aug 27, 2015	Returned to the company Stock Option (right to buy)	−1,390	$204.56	$284K	0 direct	Filing · EDGAR
May 28, 2015	Grant or award from the company	+7,400			7,400 direct	Filing · EDGAR
Jun 3, 2014	Grant or award from the company Stock Option (right to buy)	+1,390			1,390 direct	Filing · EDGAR
Apr 11, 2014	Grant or award from the company Stock Option (right to buy)	+18,800			18,800 direct	Filing · EDGAR

Abraxis BioScience Executive VP of Ops & CSO · filings 2009 to 2009

Date	Transaction	Shares	Price	Value	Held after	Source
Jul 13, 2009	Grant or award from the company	+25,000			25,000 direct	Filing · EDGAR
Jul 13, 2009	Grant or award from the company Stock Option (Right to Purchase)	+50,000			50,000 direct	Filing · EDGAR

Mgi Pharma Exec VP & Chief Scientific Off · filings 2005 to 2008

Date	Transaction	Shares	Price	Value	Held after	Source
Jan 28, 2008	Grant or award from the company	+18,083			36,333 direct	Filing · EDGAR
Jan 28, 2008	Returned to the company	−36,333	$41.00	$1.5M	0 direct	Filing · EDGAR
Jan 28, 2008	Returned to the company Employee Stock Option - Right to Buy	−50,000	$18.13	$907K	0 direct	Filing · EDGAR
Jan 28, 2008	Returned to the company Employee Stock Option - Right to Buy	−75,000	$25.87	$1.9M	0 direct	Filing · EDGAR
Jan 28, 2008	Returned to the company Employee Stock Option - Right to Buy	−17,500	$14.09	$247K	0 direct	Filing · EDGAR
Jan 28, 2008	Returned to the company Employee Stock Option - Right to Buy	−5,000	$12.94	$65K	0 direct	Filing · EDGAR
Jan 28, 2008	Returned to the company Employee Stock Option - Right to Buy	−52,500	$11.72	$615K	0 direct	Filing · EDGAR
Jan 23, 2008	Tendered in a change of control	−14,989	$41.00	$615K	18,250 direct	Filing · EDGAR
Jan 23, 2008	Tendered in a change of control	−1,835	$41.00	$75K	0 401(k) Plan	Filing · EDGAR
Aug 31, 2007	Shares withheld for tax or exercise price	−1,587	$23.57	$37K	33,239 direct	Filing · EDGAR
Jul 15, 2007	Shares withheld for tax or exercise price	−278	$25.37	$7K	34,826 direct	Filing · EDGAR
Feb 20, 2007	Grant or award from the company Employee Stock Option - Right to Buy	−50,000	$22.87	$1.1M	50,000 direct	Filing · EDGAR
Oct 3, 2006	Shares withheld for tax or exercise price	−238	$17.21	$4K	23,604 direct	Filing · EDGAR
Sep 3, 2006	Shares withheld for tax or exercise price	−2,381	$15.06	$36K	23,842 direct	Filing · EDGAR
Aug 31, 2006	Grant or award from the company	+20,000			26,223 direct	Filing · EDGAR
Aug 31, 2006	Grant or award from the company Employee Stock Option - Right to Buy	+75,000	$15.13	$1.1M	75,000 direct	Filing · EDGAR
Jul 15, 2006	Shares withheld for tax or exercise price	−277	$20.58	$6K	3,223 direct	Filing · EDGAR
Oct 3, 2005	Grant or award from the company	+3,000			3,000 direct	Filing · EDGAR

All 138 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 3, 2026	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 24, 2026	Form 4	Centessa Pharmaceuticals CNTA	Filing · EDGAR
Jun 22, 2026	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 3, 2026	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 3, 2026	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 16, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Dec 2, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
Nov 18, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Oct 22, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Sep 17, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Sep 3, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
Aug 19, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Jul 22, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Jun 24, 2025	Form 4	Centessa Pharmaceuticals CNTA	Filing · EDGAR
Jun 20, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 17, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Jun 2, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
May 20, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Apr 22, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Mar 19, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Mar 3, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
Feb 19, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Jan 23, 2025	Form 4	Eli Lilly LLY	Filing · EDGAR
Dec 17, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Dec 2, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
Nov 20, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Oct 22, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Sep 17, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Sep 3, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
Aug 20, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Jul 16, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Jun 27, 2024	Form 4	Centessa Pharmaceuticals CNTA	Filing · EDGAR
Jun 20, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 18, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Jun 3, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
May 21, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Apr 16, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Mar 19, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Mar 5, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
Feb 21, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Jan 17, 2024	Form 4	Eli Lilly LLY	Filing · EDGAR
Dec 28, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 27, 2023	Form 144	Veeva Systems VEEV	Filing · EDGAR
Dec 19, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Dec 1, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Nov 21, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Oct 17, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Sep 20, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Sep 5, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Aug 22, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Jul 18, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Jul 13, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jul 12, 2023	Form 144	Veeva Systems VEEV	Filing · EDGAR
Jun 23, 2023	Form 4	Centessa Pharmaceuticals CNTA	Filing · EDGAR
Jun 23, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 21, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Jun 5, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
May 16, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Apr 19, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Apr 3, 2023	Form 3/A	Eli Lilly LLY	Filing · EDGAR
Mar 22, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Mar 3, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Feb 22, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Jan 19, 2023	Form 4	Eli Lilly LLY	Filing · EDGAR
Dec 20, 2022	Form 4	Eli Lilly LLY	Filing · EDGAR
Dec 5, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Nov 22, 2022	Form 4	Eli Lilly LLY	Filing · EDGAR
Oct 19, 2022	Form 4	Eli Lilly LLY	Filing · EDGAR
Sep 21, 2022	Form 4	Eli Lilly LLY	Filing · EDGAR
Sep 6, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Aug 16, 2022	Form 4	Eli Lilly LLY	Filing · EDGAR
Jul 19, 2022	Form 4	Eli Lilly LLY	Filing · EDGAR
Jul 5, 2022	Form 4	Centessa Pharmaceuticals CNTA	Filing · EDGAR
Jun 22, 2022	Form 4	Eli Lilly LLY	Filing · EDGAR
Jun 13, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 2, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
May 18, 2022	Form 4	Eli Lilly LLY	Filing · EDGAR
May 16, 2022	Form 3	Eli Lilly LLY	Filing · EDGAR
Mar 3, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 3, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 3, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jul 19, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 25, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 24, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
May 27, 2021	Form 3	Centessa Pharmaceuticals CNTA	Filing · EDGAR
Apr 16, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 26, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jan 13, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 28, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 28, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jul 24, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 26, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 23, 2020	Form 4	Millendo Therapeutics	Filing · EDGAR
Jun 18, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
May 19, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Feb 19, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 16, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 19, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Aug 19, 2019	Form 3	Veeva Systems VEEV	Filing · EDGAR
Jun 21, 2019	Form 4	Millendo Therapeutics	Filing · EDGAR
Jan 22, 2019	Form 4	TESARO	Filing · EDGAR
Jan 17, 2019	Form 4	Millendo Therapeutics	Filing · EDGAR
Dec 21, 2018	Form 4	TESARO	Filing · EDGAR
Dec 11, 2018	Form 4	Millendo Therapeutics	Filing · EDGAR
Dec 11, 2018	Form 3	Millendo Therapeutics	Filing · EDGAR
Jun 22, 2018	Form 4	bluebird bio	Filing · EDGAR
Mar 5, 2018	Form 4	TESARO	Filing · EDGAR
Sep 20, 2017	Form 4	bluebird bio	Filing · EDGAR
Sep 20, 2017	Form 3	bluebird bio	Filing · EDGAR
Mar 3, 2017	Form 4	TESARO	Filing · EDGAR
Mar 3, 2016	Form 4	TESARO	Filing · EDGAR
Aug 27, 2015	Form 4	Receptos	Filing · EDGAR
Jun 1, 2015	Form 4	Receptos	Filing · EDGAR
Mar 10, 2015	Form 4	TESARO	Filing · EDGAR
Jun 5, 2014	Form 4	Receptos	Filing · EDGAR
Apr 14, 2014	Form 4	Receptos	Filing · EDGAR
Apr 14, 2014	Form 3	Receptos	Filing · EDGAR
Mar 7, 2014	Form 4/A	TESARO	Filing · EDGAR
Mar 4, 2014	Form 4	TESARO	Filing · EDGAR
Mar 8, 2013	Form 4	TESARO	Filing · EDGAR
Jul 6, 2012	Form 4	TESARO	Filing · EDGAR
Jun 27, 2012	Form 3	TESARO	Filing · EDGAR
Jul 15, 2009	Form 4	Abraxis BioScience	Filing · EDGAR
Jul 15, 2009	Form 3	Abraxis BioScience	Filing · EDGAR
Jan 30, 2008	Form 4	Mgi Pharma	Filing · EDGAR
Jan 25, 2008	Form 4	Mgi Pharma	Filing · EDGAR
Sep 5, 2007	Form 4	Mgi Pharma	Filing · EDGAR
Jul 16, 2007	Form 4	Mgi Pharma	Filing · EDGAR
Apr 19, 2007	Form 4/A	Mgi Pharma	Filing · EDGAR
Apr 19, 2007	Form 3/A	Mgi Pharma	Filing · EDGAR
Feb 22, 2007	Form 4	Mgi Pharma	Filing · EDGAR
Oct 4, 2006	Form 4	Mgi Pharma	Filing · EDGAR
Sep 5, 2006	Form 4	Mgi Pharma	Filing · EDGAR
Sep 1, 2006	Form 4	Mgi Pharma	Filing · EDGAR
Jul 17, 2006	Form 4	Mgi Pharma	Filing · EDGAR
Jul 17, 2006	Form 3/A	Mgi Pharma	Filing · EDGAR
Oct 6, 2005	Form 4	Mgi Pharma	Filing · EDGAR
Oct 6, 2005	Form 3	Mgi Pharma	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.